English  |  正體中文  |  简体中文  |  总笔数 :0  
造访人次 :  52854261    在线人数 :  647
教育部委托研究计画      计画执行:国立台湾大学图书馆
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
关于TAIR

浏览

消息

著作权

相关连结

"wei p f"的相关文件

回到依作者浏览
依题名排序 依日期排序

显示项目 21-41 / 41 (共1页)
1 
每页显示[10|25|50]项目

机构 日期 题名 作者
臺大學術典藏 2020-08-13T06:33:50Z Effusion immunocytochemistry as an alternative approach for the selection of first-line targeted therapy in advanced lung adenocarcinoma JIN-YUAN SHIH; Tsai T.-H.; Wu S.-G.; Chang Y.-L.; Wu C.-T.; Tsai M.-F.; Wei P.-F.; Yang C.-H.; Yu C.-J.; Yang P.-C.
臺大學術典藏 2020-08-12T08:25:31Z First- or second-line therapy with gefitinib produces equal survival in non-small cell lung cancer Wu J.-Y.; Yu C.-J.; Yang C.-H.; SHANG-GIN WU; Chiu Y.-H.; Gow C.-H.; Chang Y.-C.; Hsu Y.-C.; Wei P.-F.; Shih J.-Y.; Yang P.-C.
臺大學術典藏 2020-08-12T08:25:28Z Effusion immunocytochemistry as an alternative approach for the selection of first-line targeted therapy in advanced lung adenocarcinoma Tsai T.-H.;Shang-Gin Wu;Chang Y.-L.;Wu C.-T.;Tsai M.-F.;Wei P.-F.;Yang C.-H.;Yu C.-J.;Yang P.-C.;Shih J.-Y.; Tsai T.-H.; SHANG-GIN WU; Chang Y.-L.; Wu C.-T.; Tsai M.-F.; Wei P.-F.; Yang C.-H.; Yu C.-J.; Yang P.-C.; Shih J.-Y.
臺大學術典藏 2020-08-12T08:25:28Z Effusion immunocytochemistry as an alternative approach for the selection of first-line targeted therapy in advanced lung adenocarcinoma Tsai T.-H.;Shang-Gin Wu;Chang Y.-L.;Wu C.-T.;Tsai M.-F.;Wei P.-F.;Yang C.-H.;Yu C.-J.;Yang P.-C.;Shih J.-Y.; Tsai T.-H.; SHANG-GIN WU; Chang Y.-L.; Wu C.-T.; Tsai M.-F.; Wei P.-F.; Yang C.-H.; Yu C.-J.; Yang P.-C.; Shih J.-Y.
臺大學術典藏 2020-08-12T06:35:14Z Clinical outcomes in non-small cell lung cancers harboring different exon 19 deletions in EGFR Shih J.-Y.; Yang P.-C.; Wei P.-F.; Chung K.-P.;Wu S.-G.;Wu J.-Y.;Yang J.-H.;Chong-Jen Yu;Wei P.-F.;Shih J.-Y.;Yang P.-C.; Chung K.-P.; Wu S.-G.; Wu J.-Y.; Yang J.-H.; CHONG-JEN YU
臺大學術典藏 2020-08-12T06:35:14Z Clinical outcomes in non-small cell lung cancers harboring different exon 19 deletions in EGFR Shih J.-Y.; Yang P.-C.; Wei P.-F.; Chung K.-P.;Wu S.-G.;Wu J.-Y.;Yang J.-H.;Chong-Jen Yu;Wei P.-F.;Shih J.-Y.;Yang P.-C.; Chung K.-P.; Wu S.-G.; Wu J.-Y.; Yang J.-H.; CHONG-JEN YU
臺大學術典藏 2020-07-21T06:25:19Z Effusion immunocytochemistry as an alternative approach for the selection of first-line targeted therapy in advanced lung adenocarcinoma Yang P.-C.; Shih J.-Y.; Yu C.-J.; Yang C.-H.; TZU-HSIU TSAI; Wu S.-G.; Chang Y.-L.; Wu C.-T.; Tsai M.-F.; Wei P.-F.
臺大學術典藏 2020-05-26T09:27:21Z First- or second-line therapy with gefitinib produces equal survival in non-small cell lung cancer Yang P.-C.;Shih J.-Y;Wei P.-F;Hsu Y.-C;Chang Y.-C;Gow C.-H;Chiu Y.-H;Wu S.-G;Chih-Hsin Yang;Yu C.-J;Wu J.-Y; Wu J.-Y; Yu C.-J; CHIH-HSIN YANG; Wu S.-G; Chiu Y.-H; Gow C.-H; Chang Y.-C; Hsu Y.-C; Wei P.-F; Shih J.-Y; Yang P.-C.
臺大學術典藏 2020-05-26T09:27:21Z First- or second-line therapy with gefitinib produces equal survival in non-small cell lung cancer Yang P.-C.;Shih J.-Y;Wei P.-F;Hsu Y.-C;Chang Y.-C;Gow C.-H;Chiu Y.-H;Wu S.-G;Chih-Hsin Yang;Yu C.-J;Wu J.-Y; Wu J.-Y; Yu C.-J; CHIH-HSIN YANG; Wu S.-G; Chiu Y.-H; Gow C.-H; Chang Y.-C; Hsu Y.-C; Wei P.-F; Shih J.-Y; Yang P.-C.
臺大學術典藏 2020-05-26T09:27:17Z Correlation of F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value and EGFR mutations in advanced lung adenocarcinoma Yen R.-F; Cheng M.-F; Hsu Y.-C; Wei P.-F; Tsai Y.-J; Tsai M.-F; Shih J.-Y; CHIH-HSIN YANG; Yang P.-C.; Huang C.-T;Yen R.-F;Cheng M.-F;Hsu Y.-C;Wei P.-F;Tsai Y.-J;Tsai M.-F;Shih J.-Y;Chih-Hsin Yang;Yang P.-C.; Huang C.-T
臺大學術典藏 2020-05-26T09:27:17Z Correlation of F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value and EGFR mutations in advanced lung adenocarcinoma Yen R.-F; Cheng M.-F; Hsu Y.-C; Wei P.-F; Tsai Y.-J; Tsai M.-F; Shih J.-Y; CHIH-HSIN YANG; Yang P.-C.; Huang C.-T;Yen R.-F;Cheng M.-F;Hsu Y.-C;Wei P.-F;Tsai Y.-J;Tsai M.-F;Shih J.-Y;Chih-Hsin Yang;Yang P.-C.; Huang C.-T
臺大學術典藏 2020-05-26T09:27:07Z Clinical outcomes in non-small cell lung cancers harboring different exon 19 deletions in EGFR Yang P.-C.;Shih J.-Y;Wei P.-F;Yu C.-J;Chih-Hsin Yang;Wu J.-Y;Wu S.-G;Chung K.-P; Chung K.-P; Wu S.-G; Wu J.-Y; CHIH-HSIN YANG; Yu C.-J; Wei P.-F; Shih J.-Y; Yang P.-C.
臺大學術典藏 2020-05-26T09:27:07Z Clinical outcomes in non-small cell lung cancers harboring different exon 19 deletions in EGFR Yang P.-C.;Shih J.-Y;Wei P.-F;Yu C.-J;Chih-Hsin Yang;Wu J.-Y;Wu S.-G;Chung K.-P; Chung K.-P; Wu S.-G; Wu J.-Y; CHIH-HSIN YANG; Yu C.-J; Wei P.-F; Shih J.-Y; Yang P.-C.
臺大學術典藏 2020-03-07T06:56:35Z Effusion immunocytochemistry as an alternative approach for the selection of first-line targeted therapy in advanced lung adenocarcinoma Tsai T.-H.; Wu S.-G.; YIH-LEONG CHANG; Wu C.-T.; Tsai M.-F.; Wei P.-F.; Yang C.-H.; Yu C.-J.; Yang P.-C.; Shih J.-Y.
臺大學術典藏 2020-03-06T05:26:22Z Effusion immunocytochemistry as an alternative approach for the selection of first-line targeted therapy in advanced lung adenocarcinoma Tsai T.-H.; Wu S.-G.; YIH-LEONG CHANG; Wu C.-T.; Tsai M.-F.; Wei P.-F.; Yang C.-H.; Yu C.-J.; Yang P.-C.; Shih J.-Y.
臺大學術典藏 2012 Effusion immunocytochemistry as an alternative approach for the selection of first-line targeted therapy in advanced lung adenocarcinoma Shih J.-Y.;Yang P.-C;Yu C.-J;Chih-Hsin Yang;Wei P.-F;Tsai M.-F;Wu C.-T;Chang Y.-L;Wu S.-G;Tsai T.-H; Tsai T.-H; Wu S.-G; Chang Y.-L; Wu C.-T; Tsai M.-F; Wei P.-F; CHIH-HSIN YANG; Yu C.-J; Yang P.-C; Shih J.-Y.
臺大學術典藏 2012 Effusion immunocytochemistry as an alternative approach for the selection of first-line targeted therapy in advanced lung adenocarcinoma Shih J.-Y.;Yang P.-C;Yu C.-J;Chih-Hsin Yang;Wei P.-F;Tsai M.-F;Wu C.-T;Chang Y.-L;Wu S.-G;Tsai T.-H; Tsai T.-H; Wu S.-G; Chang Y.-L; Wu C.-T; Tsai M.-F; Wei P.-F; CHIH-HSIN YANG; Yu C.-J; Yang P.-C; Shih J.-Y.
臺大學術典藏 2012 Clinical outcomes in non-small cell lung cancers harboring different exon 19 deletions in EGFR Chung K.-P.;Shang-Gin Wu;Wu J.-Y.;Yang J.-H.;Yu C.-J.;Wei P.-F.;Shih J.-Y.;Yang P.-C.; Chung K.-P.; SHANG-GIN WU; Wu J.-Y.; Yang J.-H.; Yu C.-J.; Wei P.-F.; Shih J.-Y.; Yang P.-C.
臺大學術典藏 2012 Clinical outcomes in non-small cell lung cancers harboring different exon 19 deletions in EGFR Chung K.-P.;Shang-Gin Wu;Wu J.-Y.;Yang J.-H.;Yu C.-J.;Wei P.-F.;Shih J.-Y.;Yang P.-C.; Chung K.-P.; SHANG-GIN WU; Wu J.-Y.; Yang J.-H.; Yu C.-J.; Wei P.-F.; Shih J.-Y.; Yang P.-C.
臺大學術典藏 2012 Clinical outcomes in non-small cell lung cancers harboring different exon 19 deletions in EGFR Chung K.-P.;Wu S.-G.;Wu J.-Y.;Yang J.-H.;Yu C.-J.;Wei P.-F.;Jin-Yuan Shih;Yang P.-C.; Chung K.-P.; Wu S.-G.; Wu J.-Y.; Yang J.-H.; Yu C.-J.; Wei P.-F.; JIN-YUAN SHIH; Yang P.-C.
臺大學術典藏 2012 Clinical outcomes in non-small cell lung cancers harboring different exon 19 deletions in EGFR Chung K.-P.;Wu S.-G.;Wu J.-Y.;Yang J.-H.;Yu C.-J.;Wei P.-F.;Jin-Yuan Shih;Yang P.-C.; Chung K.-P.; Wu S.-G.; Wu J.-Y.; Yang J.-H.; Yu C.-J.; Wei P.-F.; JIN-YUAN SHIH; Yang P.-C.

显示项目 21-41 / 41 (共1页)
1 
每页显示[10|25|50]项目